Literature DB >> 12036298

Annotation of human chromosome 21 for relevance to Down syndrome: gene structure and expression analysis.

Katheleen Gardiner1, Dobromir Slavov, Lawrence Bechtel, Muriel Davisson.   

Abstract

Down syndrome is caused by an extra copy of human chromosome 21 and the resultant dosage-related overexpression of genes contained within it. To efficiently direct experiments to determine specific gene-phenotype correlations, it is necessary to identify all genes within 21q and assess their functional associations and expression patterns. Analysis of the complete finished sequence of 21q resulted in annotated 225 genes and gene models, most of which were incomplete and/or had little or no experimental verification. Here we correct or complete the genomic structures of 16 genes, 4 of which were not reported in the annotation of the complete sequence. Our data include the identification of six genes encoding short or ambiguous open reading frames; the identification of three cases in which alternative splicing produces two structurally unrelated protein sequences; and the identification of six genes encoding proteins with functional motifs, two genes with unusually low similarity to their orthologous mouse proteins, and four genes with significant conservation in Drosophila melanogaster. We further demonstrate that an additional nine gene models represent bona fide transcripts and develop expression patterns for these genes plus nine additional novel chromosome 21 genes and four paralogous genes mapping elsewhere in the human genome. These data have implications for generating complete transcript maps of chromosome 21 and for the entire human genome, and for defining expression abnormalities in Down syndrome and mouse models. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Year:  2002        PMID: 12036298     DOI: 10.1006/geno.2002.6782

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

Review 1.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

2.  Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions.

Authors:  Xiaolu Sturgeon; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2011-03-13       Impact factor: 2.957

3.  Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells.

Authors:  Erin L McMillan; Allison L Kamps; Samuel S Lake; Clive N Svendsen; Anita Bhattacharyya
Journal:  Am J Stem Cells       Date:  2012-06-03

Review 4.  Mouse models of Down syndrome: gene content and consequences.

Authors:  Meenal Gupta; A Ranjitha Dhanasekaran; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2016-08-18       Impact factor: 2.957

Review 5.  Minireview: the melanocortin 2 receptor accessory proteins.

Authors:  Tom R Webb; Adrian J L Clark
Journal:  Mol Endocrinol       Date:  2009-10-23

6.  A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells.

Authors:  Anita Bhattacharyya; Erin McMillan; Serene I Chen; Kyle Wallace; Clive N Svendsen
Journal:  Dev Neurosci       Date:  2009-09-09       Impact factor: 2.984

7.  Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.

Authors:  Yan Wang; Lei Gao; Sze-Wah Tse; Athena Andreadis
Journal:  Gene       Date:  2009-11-12       Impact factor: 3.688

8.  Signals of recent positive selection in a worldwide sample of human populations.

Authors:  Joseph K Pickrell; Graham Coop; John Novembre; Sridhar Kudaravalli; Jun Z Li; Devin Absher; Balaji S Srinivasan; Gregory S Barsh; Richard M Myers; Marcus W Feldman; Jonathan K Pritchard
Journal:  Genome Res       Date:  2009-03-23       Impact factor: 9.043

9.  The RNA recognition motif protein RBM11 is a novel tissue-specific splicing regulator.

Authors:  Simona Pedrotti; Roberta Busà; Claudia Compagnucci; Claudio Sette
Journal:  Nucleic Acids Res       Date:  2011-10-07       Impact factor: 16.971

10.  MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.

Authors:  Li F Chan; Tom R Webb; Teng-Teng Chung; Eirini Meimaridou; Sadani N Cooray; Leonardo Guasti; J Paul Chapple; Michaela Egertová; Maurice R Elphick; Michael E Cheetham; Louise A Metherell; Adrian J L Clark
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.